Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years

IF 2.5 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart Failure Clinics Pub Date : 2023-07-11 DOI:10.1016/j.hfc.2023.05.005

Omar Jawaid MD , Christopher Salerno MD , Ashwin Ravichandran MD

引用次数: 0

查看原文本刊更多论文

左心室辅助装置与最新技术：HeartMate 3 5年

左心室辅助装置(lvad)或心脏移植是治疗终末期心力衰竭患者的两种常用方法。供体心脏的可用性不足以满足晚期心力衰竭患者的需要。对于那些不能等待或不适合心脏移植的患者，左心室辅助装置为移植提供了一个潜在的替代方案。这一领域在过去的20年里取得了巨大的进步。在这篇综述中，就当前一代lvad的现状进行了总结。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart Failure Clinics CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

5.40

自引率

2.90%

发文量

期刊介绍： Heart failure is quickly becoming the most pressing health problem in the United States. Heart Failure Clinics provides practical, concise and easy-to-read coverage that encompasses everything you need to know about the current literature. Topics include acute decompensated heart failure, arrhythmias and sudden cardiac death, ventricular dysfunction, comorbidities of heart failure, diastolic dysfunction, genetic evaluation, ischemic heart disease, pulmonary arterial hypertension, and surgery/transplantation.